Stock Events

Stock Events

USBC 

$0.39
0
+$0.05+15.27% Today

Statistics

Day High
0.39
Day Low
0.36
52W High
-
52W Low
-
Volume
32,440
Avg. Volume
-
Mkt Cap
150.06M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

20MayExpected
Q3 2025
Next
Next
-2.8
-2.67
-2.53
-2.4
Expected EPS
-2.8
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-48.71MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow USBC.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. competes directly in the biotechnology sector focusing on innovative therapeutics, similar to US Biotec.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences operates in the same biopharmaceutical field, developing treatments that overlap with US Biotec's product lines.
Biogen
BIIB
Mkt Cap22.63B
Biogen Inc. focuses on neurological diseases and advanced biologics, competing in the same specialty areas as US Biotec.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals is involved in creating targeted therapies for serious diseases, a direct competitor in innovation-driven biotech.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals is known for its integrated biopharmaceutical development, similar to US Biotec's approach.
Illumina
ILMN
Mkt Cap18.99B
Illumina Inc. provides genomics solutions, competing with US Biotec in the biotech sector's push towards personalized medicine.
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Alnylam Pharmaceuticals works on RNAi therapeutics, competing in the innovative drug development space with US Biotec.
Incyte
INCY
Mkt Cap18.35B
Incyte Corporation offers novel therapeutics, directly competing with US Biotec in the field of biopharmaceuticals.
Exelixis
EXEL
Mkt Cap10.41B
Exelixis, Inc. focuses on cancer treatments, competing in the oncology segment where US Biotec is also active.

About

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Show more...
CEO
ISIN
US4992382022

Listings

XASE
US
USBC
BOATS
BOATS
USBC.BOATS

0 Comments

Share your thoughts

FAQ

What is USBC stock price today?▼
The current price of USBC.BOATS is $0.39 USD — it has increased by +15.27% in the past 24 hours. Watch USBC stock price performance more closely on the chart.
What is USBC stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange USBC stocks are traded under the ticker USBC.BOATS.
What is USBC market cap?▼
Today USBC has the market capitalization of 150.06M
When is the next USBC earnings date?▼
USBC is going to release the next earnings report on May 20, 2026.
What is USBC revenue for the last year?▼
USBC revenue for the last year amounts to 0 USD.
What is USBC net income for the last year?▼
USBC.BOATS net income for the last year is -48.71M USD.
When did USBC complete a stock split?▼
USBC has not had any recent stock splits.